Regulation of hdm2 by stress-induced hdm2alt1 in tumor and nontumorigenic cell lines correlating with p53 stability.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Cancer Research

• Publication date

  2006-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1158/0008-5472.CAN-05-3013PMID 17018602
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Genomic organisation of the human MDM2 oncogene and relationship to its alternatively spliced mRNAs.

  2004cited by this paper
• An Alternative Splice Form of Mdm2 Induces p53-independent Cell Growth and Tumorigenesis*

  2004cited by this paper
• Ribosomal Protein L23 Activates p53 by Inhibiting MDM2 Function in Response to Ribosomal Perturbation but Not to Translation Inhibition

  2004cited by this paper
• Expression of alternatively and aberrantly spliced transcripts of the MDM2 mRNA is not tumor-specific.

  2004cited by this paper
• Regulation of HDM2 activity by the ribosomal protein L11.

  2003cited by this paper
• Tumor promotion by Mdm2 splice variants unable to bind p53.

  2003cited by this paper
• p53-independent functions of MDM2.

  2003cited by this paper
• Nuclear and cytoplasmic degradation of endogenous p53 and HDM2 occurs during down‐regulation of the p53 response after multiple types of DNA damage

  2003cited by this paper
• ARF Function Does Not Require p53 Stabilization or Mdm2 Relocalization

  2002cited by this paper
• Alternative and aberrant splicing of MDM2 mRNA in human cancer.

  2002cited by this paper
• p53-Mdm2--the affair that never ends.

  2002cited by this paper
• An alternatively spliced HDM2 product increases p53 activity by inhibiting HDM2

  2001cited by this paper
• Activation and activities of the p53 tumour suppressor protein

  2001cited by this paper
• Alternative and aberrant messenger RNA splicing of the mdm2 oncogene in invasive breast cancer.

  2001cited by this paper
• P53-independent down-regulation of Mdm2 in human cancer cells treated with adriamycin.

  2000cited by this paper
• The ARF/p53 pathway.

  2000cited by this paper
• MDM2--master regulator of the p53 tumor suppressor protein.

  2000cited by this paper
• Role of two upstream open reading frames in the translational control of oncogene mdm2

  1999cited by this paper
• The human oncoprotein MDM2 arrests the cell cycle: elimination of its cell‐cycle‐inhibitory function induces tumorigenesis

  1998cited by this paper
• Genomic organization of the mouse double minute 2 gene.

  1996cited by this paper
• Alternatively spliced mdm2 transcripts with loss of p53 binding domain sequences: Transforming ability and frequent detection in human cancer

  1996cited by this paper
• The mdm-2 oncogene can overcome wild-type p53 suppression of transformed cell growth

  1993cited by this paper
• Tumorigenic potential associated with enhanced expression of a gene that is amplified in a mouse tumor cell line.

  1991cited by this paper
• Molecular analysis and chromosomal mapping of amplified genes isolated from a transformed mouse 3T3 cell line

  1987cited by this paper

• Blockade of interleukin-6 (IL-6) signaling in dedifferentiated liposarcoma (DDLPS) decreases mouse double minute 2 (MDM2) oncogenicity via alternative splicing

  2024cites this paper
• SRSF7 downregulation induces cellular senescence through generation of MDM2 variants

  2023cites this paper
• SRSF2 Regulation of MDM2 Reveals Splicing as a Therapeutic Vulnerability of the p53 Pathway

  2019cites this paper
• A novel mouse model of rhabdomyosarcoma underscores the dichotomy of MDM2-ALT1 function in vivo

  2017cites this paper
• Impact of the MDM2 splice-variants MDM2-A, MDM2-B and MDM2-C on cytotoxic stress response in breast cancer cells

  2017cites this paper
• Estradiol shows anti-skin cancer activities through decreasing MDM2 expression

  2016cites this paper
• The Involvement of Splicing Factor hnRNP A1 in UVB‐induced Alternative Splicing of hdm2

  2016cites this paper
• Aberrant splicing of the DMP1‐ARF‐MDM2‐p53 pathway in cancer

  2016cites this paper
• Exploring Chromatin-bound MDM2 Functions in Compromised Transcriptional Regulation of p53 Target Genes

  2015cites this paper
• ROS and p53 in Regulation of UVB‐induced HDM2 Alternative Splicing

  2015cites this paper
• Splicing factor SRSF1 negatively regulates alternative splicing of MDM2 under damage

  2015cites this paper
• Splicing factor SRSF 1 negatively regulates alternative splicing of MDM 2 under damage

  2015cites this paper
• Les protéines Staufen et leurs rôles dans la régulation posttranscriptionnelle de l’expression des gènes, la réponse aux dommages à l’ADN et le cycle cellulaire

  2014cites this paper
• Stress-Induced Alternative Splice Forms of MDM2 and MDMX Modulate the p53-Pathway in Distinct Ways

  2014cites this paper
• Splice variants of MDM2 in oncogenesis.

  2014cites this paper
• The Splicing Factor FUBP1 Is Required for the Efficient Splicing of Oncogene MDM2 Pre-mRNA*

  2014cites this paper
• Stress-induced isoforms of MDM2 and MDM4 correlate with high-grade disease and an altered splicing network in pediatric rhabdomyosarcoma.

  2013influential citation
• Endogenous Human MDM2-C Is Highly Expressed in Human Cancers and Functions as a p53-Independent Growth Activator

  2013cites this paper
• PDIP38 is translocated to the spliceosomes/nuclear speckles in response to UV-induced DNA damage and is required for UV-induced alternative splicing of MDM2

  2013cites this paper
• RNA Splicing: A New Player in the DNA Damage Response

  2013cites this paper
• Alternative splicing regulation and cell lineage differentiation.

  2012cites this paper
• Splicing up mdm2 for cancer proteome diversity.

  2012cites this paper
• The emerging role of pre-messenger RNA splicing in stress responses: Sending alternative messages and silent messengers

  2011cites this paper
• Investigating the role of novel fusion proteins of interferon in melanoma

  2010cites this paper
• Cotranscriptional exon skipping in the genotoxic stress response

  2010cites this paper
• The MDM2-A Splice Variant of MDM2 Alters Transformation In vitro and the Tumor Spectrum in Both Arf- and p53-Null Models of Tumorigenesis

  2009cites this paper
• MDM2 and MDM4 splicing: an integral part of the cancer spliceome.

  2009cites this paper
• Conserved sequences in the final intron of MDM2 are essential for the regulation of alternative splicing of MDM2 in response to stress.

  2009cites this paper
• Respuesta al daño al ADN: un ejemplo de acoplamiento entre transcripción y splicing alternativo

  2009cites this paper
• Full-length hdmX transcripts decrease following genotoxic stress

  2008cites this paper
• The WSB1 Gene Is Involved in Pancreatic Cancer Progression

  2008cites this paper
• Genome-wide detection of testis- and testicular cancer-specific alternative splicing.

  2007cites this paper
• THE FUNCTIONAL SIGNIFICANCE OF AN ALTERNATELY SPLICED PRODUCT OF THE HDM2 GENE

  2007influential citation